What is Illumina Inc's earnings per share (EPS)?

Illumina Inc (ILMN) reported diluted earnings per share of $5.45 for fiscal year 2025. This represents a 170.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Illumina Inc Financials

ILMN

Source SEC Filings (10-K/10-Q) Updated Dec 28, 2025 Currency USD FYE December

This page shows Illumina Inc (ILMN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 61/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Illumina Inc has an operating margin of 18.6%, meaning the company retains $19 of operating profit per $100 of revenue. This results in a moderate score of 64/100, indicating healthy but not exceptional operating efficiency. This is up from -19.1% the prior year.

Growth

Illumina Inc's revenue declined 0.7% year-over-year, from $4.4B to $4.3B. This contraction results in a growth score of 32/100.

Leverage

Illumina Inc carries a low D/E ratio of 1.44, meaning only $1.44 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 73/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Illumina Inc's current ratio of 2.08 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Illumina Inc converts 21.4% of revenue into free cash flow ($931.0M). This strong cash generation earns a score of 79/100.

Returns

Illumina Inc earns a strong 31.2% return on equity (ROE), meaning it generates $31 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 80/100. This is up from -51.5% the prior year.

Altman Z-Score Safe

4.16

Illumina Inc scores 4.16, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($18.8B) relative to total liabilities ($3.9B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Strong

7/9

Illumina Inc passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.27x

For every $1 of reported earnings, Illumina Inc generates $1.27 in operating cash flow ($1.1B OCF vs $850.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

8.0x

Illumina Inc earns $8.0 in operating income for every $1 of interest expense ($807.0M vs $101.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.3B

YoY-0.7%

5Y CAGR+4.2%

10Y CAGR+11.8%

Illumina Inc generated $4.3B in revenue in fiscal year 2025. This represents a decrease of 0.7% from the prior year.

EBITDA

$1.1B

YoY+324.8%

5Y CAGR-1.7%

10Y CAGR+16.6%

Illumina Inc's EBITDA was $1.1B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 324.8% from the prior year.

Net Income

$850.0M

YoY+169.5%

5Y CAGR-3.2%

10Y CAGR+21.1%

Illumina Inc reported $850.0M in net income in fiscal year 2025. This represents an increase of 169.5% from the prior year.

EPS (Diluted)

$5.45

YoY+170.9%

5Y CAGR-4.2%

10Y CAGR+19.7%

Illumina Inc earned $5.45 per diluted share (EPS) in fiscal year 2025. This represents an increase of 170.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$931.0M

YoY+31.3%

5Y CAGR+2.0%

10Y CAGR+11.7%

Illumina Inc generated $931.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 31.3% from the prior year.

Cash & Debt

$1.4B

YoY+25.8%

5Y CAGR-7.0%

10Y CAGR+7.1%

Illumina Inc held $1.4B in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

153M

YoY-3.5%

5Y CAGR+0.8%

10Y CAGR+1.8%

Illumina Inc had 153M shares outstanding in fiscal year 2025. This represents a decrease of 3.5% from the prior year.

Margins & Returns

Gross Margin

66.1%

YoY+0.6pp

5Y CAGR-3.5pp

10Y CAGR+1.9pp

Illumina Inc's gross margin was 66.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.6 percentage points from the prior year.

Operating Margin

18.6%

YoY+37.6pp

5Y CAGR-9.2pp

10Y CAGR+9.1pp

Illumina Inc's operating margin was 18.6% in fiscal year 2025, reflecting core business profitability. This is up 37.6 percentage points from the prior year.

Net Margin

19.6%

YoY+47.5pp

5Y CAGR-8.7pp

10Y CAGR+10.8pp

Illumina Inc's net profit margin was 19.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 47.5 percentage points from the prior year.

Return on Equity

31.2%

YoY+82.8pp

5Y CAGR+9.5pp

10Y CAGR+23.0pp

Illumina Inc's ROE was 31.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 82.8 percentage points from the prior year.

Capital Allocation

R&D Spending

$967.0M

YoY-17.3%

5Y CAGR+8.4%

10Y CAGR+13.3%

Illumina Inc invested $967.0M in research and development in fiscal year 2025. This represents a decrease of 17.3% from the prior year.

Share Buybacks

$742.0M

YoY+539.7%

5Y CAGR+18.0%

10Y CAGR+31.0%

Illumina Inc spent $742.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 539.7% from the prior year.

Capital Expenditures

$148.0M

YoY+15.6%

5Y CAGR-6.7%

10Y CAGR+6.4%

Illumina Inc invested $148.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 15.6% from the prior year.

ILMN Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Revenue	$4.3B-0.7%	$4.4B-2.9%	$4.5B-0.5%	$4.5B+39.7%	$3.2B-8.6%	$3.5B
Cost of Revenue	$1.5B-2.5%	$1.5B-14.1%	$1.8B+28.3%	$1.4B+32.4%	$1.0B-3.7%	$1.1B
Gross Profit	$2.9B+0.3%	$2.9B+4.3%	$2.7B-13.0%	$3.2B+43.2%	$2.2B-10.7%	$2.5B
R&D Expenses	$967.0M-17.3%	$1.2B-13.7%	$1.4B+14.3%	$1.2B+73.8%	$682.0M+5.4%	$647.0M
SG&A Expenses	$1.1B-0.5%	$1.1B-32.3%	$1.6B-22.9%	$2.1B+122.3%	$941.0M+12.7%	$835.0M
Operating Income	$807.0M+196.9%	-$833.0M+22.1%	-$1.1B-769.1%	-$123.0M-121.2%	$580.0M-41.1%	$985.0M
Interest Expense	$101.0M+1.0%	$100.0M+29.9%	$77.0M+26.2%	$61.0M+24.5%	$49.0M-5.8%	$52.0M
Income Tax	$236.0M+436.4%	$44.0M0.0%	$44.0M-63.9%	$122.0M-39.0%	$200.0M+56.3%	$128.0M
Net Income	$850.0M+169.5%	-$1.2B-5.3%	-$1.2B-252.4%	$762.0M+16.2%	$656.0M-34.5%	$1.0B
EPS (Diluted)	$5.45+170.9%	$-7.69-4.8%	$-7.34-245.6%	$5.04+13.3%	$4.45-34.0%	$6.74

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$1.2B+6.9%	$1.1B+2.4%	$1.1B+1.7%	$1.0B-5.7%	$1.1B+2.2%	$1.1B-2.9%	$1.1B+3.3%	$1.1B
Cost of Revenue	$400.0M+14.0%	$351.0M-3.6%	$364.0M+1.7%	$358.0M-4.8%	$376.0M+12.2%	$335.0M-14.3%	$391.0M-4.4%	$409.0M
Gross Profit	$759.0M+3.5%	$733.0M+5.5%	$695.0M+1.8%	$683.0M-6.2%	$728.0M-2.3%	$745.0M+3.3%	$721.0M+8.1%	$667.0M
R&D Expenses	$239.0M+4.4%	$229.0M-7.3%	$247.0M-2.0%	$252.0M0.0%	$252.0M-0.4%	$253.0M-22.2%	$325.0M-4.1%	$339.0M
SG&A Expenses	$308.0M+11.2%	$277.0M+18.4%	$234.0M-12.4%	$267.0M0.0%	$267.0M+11.7%	$239.0M+62.6%	$147.0M-66.5%	$439.0M
Operating Income	$202.0M-11.0%	$227.0M+6.1%	$214.0M+30.5%	$164.0M-5.7%	$174.0M-76.5%	$741.0M+145.3%	-$1.6B-1374.8%	-$111.0M
Interest Expense	$26.0M+4.0%	$25.0M0.0%	$25.0M0.0%	$25.0M-3.8%	$26.0M-27.8%	$36.0M+80.0%	$20.0M+11.1%	$18.0M
Income Tax	$44.0M-37.1%	$70.0M-1.4%	$71.0M+39.2%	$51.0M	$0-100.0%	$15.0M+25.0%	$12.0M-29.4%	$17.0M
Net Income	$334.0M+122.7%	$150.0M-36.2%	$235.0M+79.4%	$131.0M-29.6%	$186.0M-73.6%	$705.0M+135.5%	-$2.0B-1477.8%	-$126.0M
EPS (Diluted)	N/A	$0.98-34.2%	$1.49+81.7%	$0.82	N/A	$4.42+135.4%	$-12.48-1479.7%	$-0.79

ILMN Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Total Assets	$6.6B+5.4%	$6.3B-37.7%	$10.1B-33.8%	$15.3B+74.5%	$8.8B+19.7%	$7.3B
Current Assets	$3.3B+19.8%	$2.7B+5.3%	$2.6B-5.3%	$2.8B-51.2%	$5.6B+26.8%	$4.5B
Cash & Equivalents	$1.4B+25.8%	$1.1B+7.5%	$1.0B-22.4%	$1.4B-69.5%	$4.4B+117.1%	$2.0B
Inventory	$564.0M+3.1%	$547.0M-6.8%	$587.0M+26.2%	$465.0M+27.7%	$364.0M+1.4%	$359.0M
Accounts Receivable	$854.0M+16.2%	$735.0M+0.1%	$734.0M+19.5%	$614.0M+18.8%	$517.0M-9.8%	$573.0M
Goodwill	$1.1B0.0%	$1.1B-56.3%	$2.5B-64.2%	$7.1B+693.0%	$897.0M0.0%	$897.0M
Total Liabilities	$3.9B-0.2%	$3.9B-10.0%	$4.4B-0.3%	$4.4B+14.2%	$3.8B+41.8%	$2.7B
Current Liabilities	$1.6B+2.5%	$1.5B-1.5%	$1.6B+5.4%	$1.5B+17.5%	$1.3B+90.7%	$665.0M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	$1.1B
Total Equity	$2.7B+14.7%	$2.4B-58.7%	$5.7B-47.3%	$10.9B+121.4%	$4.9B+6.7%	$4.6B
Retained Earnings	-$392.0M+68.4%	-$1.2B-6436.8%	-$19.0M-100.3%	$5.6B+15.6%	$4.9B+19.7%	$4.1B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$6.6B+7.6%	$6.2B+1.5%	$6.1B-1.5%	$6.2B-1.9%	$6.3B+4.8%	$6.0B-1.1%	$6.1B-39.4%	$10.0B
Current Assets	$3.3B+17.6%	$2.8B+5.9%	$2.6B-1.2%	$2.7B-2.7%	$2.7B+15.7%	$2.4B-3.5%	$2.5B-4.8%	$2.6B
Cash & Equivalents	$1.4B+35.0%	$1.1B+12.4%	$934.0M-16.1%	$1.1B-1.2%	$1.1B+29.7%	$869.0M-5.5%	$920.0M-17.0%	$1.1B
Inventory	$564.0M-4.4%	$590.0M+2.6%	$575.0M+7.1%	$537.0M-1.8%	$547.0M-4.7%	$574.0M+2.3%	$561.0M-3.9%	$584.0M
Accounts Receivable	$854.0M+17.1%	$729.0M+4.0%	$701.0M+0.3%	$699.0M-4.9%	$735.0M+5.2%	$699.0M+9.0%	$641.0M+0.9%	$635.0M
Goodwill	$1.1B0.0%	$1.1B0.0%	$1.1B0.0%	$1.1B0.0%	$1.1B0.0%	$1.1B+3.2%	$1.1B-57.6%	$2.5B
Total Liabilities	$3.9B+3.3%	$3.8B-0.9%	$3.8B+0.4%	$3.8B-3.0%	$3.9B+1.1%	$3.9B-16.3%	$4.6B+7.9%	$4.3B
Current Liabilities	$1.6B-19.2%	$2.0B+34.3%	$1.5B+1.5%	$1.4B-6.9%	$1.5B+58.7%	$975.0M-55.8%	$2.2B+49.8%	$1.5B
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$2.7B+14.4%	$2.4B+5.4%	$2.3B-4.6%	$2.4B-0.2%	$2.4B+11.7%	$2.1B+48.0%	$1.4B-75.0%	$5.7B
Retained Earnings	-$392.0M+46.0%	-$726.0M+17.1%	-$876.0M+21.2%	-$1.1B+10.5%	-$1.2B+13.0%	-$1.4B+33.1%	-$2.1B-1371.0%	-$145.0M

ILMN Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Operating Cash Flow	$1.1B+28.9%	$837.0M+75.1%	$478.0M-12.3%	$545.0M-49.5%	$1.1B+2.8%	$1.1B
Capital Expenditures	$148.0M+15.6%	$128.0M-34.4%	$195.0M-6.3%	$208.0M+10.1%	$189.0M-9.6%	$209.0M
Free Cash Flow	$931.0M+31.3%	$709.0M+150.5%	$283.0M-16.0%	$337.0M-62.2%	$891.0M+5.8%	$842.0M
Investing Cash Flow	-$55.0M+69.1%	-$178.0M+22.9%	-$231.0M+78.4%	-$1.1B-93.0%	-$554.0M-174.4%	$745.0M
Financing Cash Flow	-$744.0M-30.5%	-$570.0M+52.9%	-$1.2B-2272.5%	-$51.0M+93.3%	-$766.0M+14.6%	-$897.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$742.0M+539.7%	$116.0M	$0	$0-100.0%	$736.0M+127.2%	$324.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$321.0M+13.0%	$284.0M+21.4%	$234.0M-2.5%	$240.0M-34.1%	$364.0M+15.2%	$316.0M+295.0%	$80.0M+3.9%	$77.0M
Capital Expenditures	$55.0M+77.4%	$31.0M+3.3%	$30.0M-6.3%	$32.0M+10.3%	$29.0M-9.4%	$32.0M+3.2%	$31.0M-13.9%	$36.0M
Free Cash Flow	$266.0M+5.1%	$253.0M+24.0%	$204.0M-1.9%	$208.0M-37.9%	$335.0M+18.0%	$284.0M+479.6%	$49.0M+19.5%	$41.0M
Investing Cash Flow	$108.0M+311.8%	-$51.0M-4.1%	-$49.0M+22.2%	-$63.0M-31.3%	-$48.0M-17.1%	-$41.0M0.0%	-$41.0M+14.6%	-$48.0M
Financing Cash Flow	-$63.0M+45.2%	-$115.0M+69.0%	-$371.0M-90.3%	-$195.0M-314.9%	-$47.0M+85.8%	-$332.0M-46.9%	-$226.0M-745.7%	$35.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$42.0M-67.7%	$130.0M-64.9%	$370.0M+85.0%	$200.0M+1076.5%	$17.0M-82.8%	$99.0M	$0	$0

ILMN Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Gross Margin	66.1%+0.6pp	65.4%+4.5pp	60.9%-8.8pp	69.7%+1.7pp	68.0%-1.6pp	69.6%
Operating Margin	18.6%+37.6pp	-19.1%+4.7pp	-23.7%-21.0pp	-2.7%-20.6pp	17.9%-9.9pp	27.8%
Net Margin	19.6%+47.5pp	-28.0%-2.2pp	-25.8%-42.6pp	16.8%-3.4pp	20.3%-8.0pp	28.3%
Return on Equity	31.2%+82.8pp	-51.5%-31.3pp	-20.2%-27.2pp	7.0%-6.3pp	13.3%-8.4pp	21.7%
Return on Assets	12.8%+32.2pp	-19.4%-7.9pp	-11.5%-16.5pp	5.0%-2.5pp	7.5%-6.2pp	13.7%
Current Ratio	2.08+0.3	1.77+0.1	1.66-0.2	1.85-2.6	4.45-2.2	6.69
Debt-to-Equity	1.44-0.2	1.66+0.9	0.76+0.4	0.40-0.4	0.78+0.5	0.25
FCF Margin	21.4%+5.2pp	16.2%+9.9pp	6.3%-1.2pp	7.4%-20.1pp	27.5%+3.7pp	23.8%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	65.5%-2.1pp	67.6%+2.0pp	65.6%+0.0pp	65.6%-0.3pp	65.9%-3.0pp	69.0%+4.1pp	64.8%+2.8pp	62.0%
Operating Margin	17.4%-3.5pp	20.9%+0.7pp	20.2%+4.5pp	15.8%0.0pp	15.8%-52.9pp	68.6%+215.8pp	-147.2%-136.9pp	-10.3%
Net Margin	28.8%+15.0pp	13.8%-8.3pp	22.2%+9.6pp	12.6%-4.3pp	16.9%-48.4pp	65.3%+244.1pp	-178.8%-167.1pp	-11.7%
Return on Equity	12.3%+6.0pp	6.3%-4.1pp	10.4%+4.9pp	5.5%-2.3pp	7.8%-25.3pp	33.2%+171.6pp	-138.4%-136.2pp	-2.2%
Return on Assets	5.0%+2.6pp	2.4%-1.4pp	3.9%+1.7pp	2.1%-0.8pp	2.9%-8.8pp	11.7%+44.4pp	-32.7%-31.4pp	-1.3%
Current Ratio	2.08+0.6	1.43-0.4	1.81-0.0	1.86+0.1	1.77-0.7	2.43+1.3	1.11-0.6	1.75
Debt-to-Equity	1.44-0.2	1.59-0.1	1.70+0.1	1.61-0.0	1.66-0.2	1.83-1.4	3.23+2.5	0.75
FCF Margin	22.9%-0.4pp	23.3%+4.1pp	19.3%-0.7pp	20.0%-10.4pp	30.3%+4.0pp	26.3%+21.9pp	4.4%+0.6pp	3.8%

Similar Companies

PERKINELMER INC PKI

$14.5B

Waters WAT

$29.2B

Medpace Holdings MEDP

$13.6B

Labcorp Holdings Inc LH

$22.0B

Quest Diagnostics Inc DGX

$21.5B

Frequently Asked Questions

What is Illumina Inc's annual revenue?

Illumina Inc (ILMN) reported $4.3B in total revenue for fiscal year 2025. This represents a -0.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Illumina Inc's revenue growing?

Illumina Inc (ILMN) revenue declined by 0.7% year-over-year, from $4.4B to $4.3B in fiscal year 2025.

Is Illumina Inc profitable?

Yes, Illumina Inc (ILMN) reported a net income of $850.0M in fiscal year 2025, with a net profit margin of 19.6%.

What is Illumina Inc's EBITDA?

Illumina Inc (ILMN) had EBITDA of $1.1B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Illumina Inc's gross margin?

Illumina Inc (ILMN) had a gross margin of 66.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Illumina Inc's operating margin?

Illumina Inc (ILMN) had an operating margin of 18.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Illumina Inc's net profit margin?

Illumina Inc (ILMN) had a net profit margin of 19.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Illumina Inc's return on equity (ROE)?

Illumina Inc (ILMN) has a return on equity of 31.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Illumina Inc's free cash flow?

Illumina Inc (ILMN) generated $931.0M in free cash flow during fiscal year 2025. This represents a 31.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Illumina Inc's operating cash flow?

Illumina Inc (ILMN) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Illumina Inc's total assets?

Illumina Inc (ILMN) had $6.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Illumina Inc's capital expenditures?

Illumina Inc (ILMN) invested $148.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Illumina Inc spend on research and development?

Illumina Inc (ILMN) invested $967.0M in research and development during fiscal year 2025.

Does Illumina Inc buy back shares?

Yes, Illumina Inc (ILMN) spent $742.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Illumina Inc have outstanding?

Illumina Inc (ILMN) had 153M shares outstanding as of fiscal year 2025.

What is Illumina Inc's current ratio?

Illumina Inc (ILMN) had a current ratio of 2.08 as of fiscal year 2025, which is generally considered healthy.

What is Illumina Inc's debt-to-equity ratio?

Illumina Inc (ILMN) had a debt-to-equity ratio of 1.44 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Illumina Inc's return on assets (ROA)?

Illumina Inc (ILMN) had a return on assets of 12.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Illumina Inc's Altman Z-Score?

Illumina Inc (ILMN) has an Altman Z-Score of 4.16, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Illumina Inc's Piotroski F-Score?

Illumina Inc (ILMN) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Illumina Inc's earnings high quality?

Illumina Inc (ILMN) has an earnings quality ratio of 1.27x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Illumina Inc cover its interest payments?

Illumina Inc (ILMN) has an interest coverage ratio of 8.0x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Illumina Inc?

Illumina Inc (ILMN) scores 61 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.